Trademark: 88330079
Word
ENZYVANT
Status Date
Tuesday, June 9, 2020
Registration Number
6072404
Registration Date
Tuesday, June 9, 2020
Filing Date
Thursday, March 7, 2019
Published for Opposition
Tuesday, March 24, 2020
5 Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto
42 Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials
44 Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
Color is not claimed as a feature of the mark.
The mark consists of a design of ovals forming two concentric circles with the wording "ENZYVANT" appearing to the right of the design.
Jun 9, 2020
Registered-Principal Register
Mar 24, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 24, 2020
Published For Opposition
Mar 4, 2020
Notification Of Notice Of Publication E-Mailed
Feb 19, 2020
Law Office Publication Review Completed
Feb 10, 2020
Assigned To Lie
Jan 31, 2020
Approved For Pub - Principal Register
Jan 31, 2020
Previous Allowance Count Withdrawn
Jan 31, 2020
Approved For Pub - Principal Register
Jan 27, 2020
Teas/Email Correspondence Entered
Jan 26, 2020
Correspondence Received In Law Office
Jan 26, 2020
Teas Request For Reconsideration Received
Jan 25, 2020
Notification Of Final Refusal Emailed
Jan 25, 2020
Final Refusal E-Mailed
Jan 25, 2020
Final Refusal Written
Nov 14, 2019
Teas/Email Correspondence Entered
Nov 13, 2019
Correspondence Received In Law Office
Nov 13, 2019
Teas Response To Office Action Received
Jul 25, 2019
Assigned To Examiner
May 18, 2019
Notification Of Non-Final Action E-Mailed
May 18, 2019
Non-Final Action E-Mailed
May 18, 2019
Non-Final Action Written
May 9, 2019
Assigned To Examiner
Mar 27, 2019
Notice Of Design Search Code E-Mailed
Mar 26, 2019
New Application Office Supplied Data Entered In Tram
Mar 11, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
